Evidence map›Paper›PMID 35014255›Full record

ArticleJournal of medicinal chemistry2022

Systematic Variation of Both the Aromatic Cage and Dialkyllysine via GCE-SAR Reveal Mechanistic Insights in CBX5 Reader Protein Binding.

Kelsey M Kean, Stefanie A Baril, Kelsey N Lamb, Sarah N Dishman, Joseph W Treacy, Kendall N Houk, Eric M Brustad, Lindsey I James, Marcey L Waters

Open access · greenAbstract read
In one paragraph

Article in Journal of medicinal chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Contribution of Electrostatic CHJournal of the American Chemical Society · 2024
    Article
  6. Article
  7. Engineered Biocatalytic Synthesis of β-N-Substituted-α-Amino Acids.Angewandte Chemie (International ed. in English) · 2023
    Article
  8. Article
  9. Chemical tools targeting readers of lysine methylation.Current opinion in chemical biology · 2023
    Review
  10. Article
  11. Virtual Special Issue: Epigenetics 2022.ACS pharmacology & translational science · 2022
    Article
  12. Virtual Special Issue: Epigenetics 2022.ACS medicinal chemistry letters · 2022
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Kelsey M KeanDepartment of Chemistry, University of North Carolina at Chapel Hill, CB 3290, Chapel Hill, North Carolina 27599 United States.ORCID 0000-0003-4981-9810
Stefanie A BarilDepartment of Chemistry, University of North Carolina at Chapel Hill, CB 3290, Chapel Hill, North Carolina 27599 United States.ORCID 0000-0003-3249-2866
Kelsey N LambCenter for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 United States.
Sarah N DishmanCenter for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 United States.ORCID 0000-0003-3110-5828
Joseph W TreacyDepartment of Chemistry and Biochemistry, University of California, Box 951569, Los Angeles, California 90095 United States.
Kendall N HoukDepartment of Chemistry and Biochemistry, University of California, Box 951569, Los Angeles, California 90095 United States.ORCID 0000-0002-8387-5261
Eric M BrustadDepartment of Chemistry, University of North Carolina at Chapel Hill, CB 3290, Chapel Hill, North Carolina 27599 United States.ORCID 0000-0002-7031-5433
Lindsey I JamesCenter for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 United States.ORCID 0000-0002-6034-7116
Marcey L WatersDepartment of Chemistry, University of North Carolina at Chapel Hill, CB 3290, Chapel Hill, North Carolina 27599 United States.ORCID 0000-0002-4917-5755
University of North Carolina at Chapel Hill · USUniversity of California, Los Angeles · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI David Darr · 1985 to 2026
$201.5M
SEEDING POSTDOCTORAL INNOVATORS IN RESEARCH &EDUCATIONK12GM000678 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DONALD T LYSLE, Kathryn Joanna Reissner · 1999 to 2026
$30.9M
POLYCOMB REPRESSIVE COMLEXE AS KEY REGULATORS OF HIV LATENCY AND TARGETS FOR LATENCY REVERSALR61DA047023 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JAMES, LINDSEY INGERMAN · 2018 to 2020
$2.7M
Origins of Ligand Binding and Selectivity in Methyllysine Reader and Writer ProteinsR01GM118499 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WATERS, MARCEY L · 2017 to 2022
$1.6M
NCI NIH HHS P30 CA016086NIDA NIH HHS R61 DA047023NIGMS NIH HHS K12 GM000678NIGMS NIH HHS R01 GM118499
6 · The paper itself

Abstract

Development of inhibitors for histone methyllysine reader proteins is an active area of research due to the importance of reader protein-methyllysine interactions in transcriptional regulation and disease. Optimized peptide-based chemical probes targeting methyllysine readers favor larger alkyllysine residues in place of methyllysine. However, the mechanism by which these larger substituents drive tighter binding is not well understood. This study describes the development of a two-pronged approach combining genetic code expansion (GCE) and structure-activity relationships (SAR) through systematic variation of both the aromatic binding pocket in the protein and the alkyllysine residues in the peptide to probe inhibitor recognition in the CBX5 chromodomain. We demonstrate a novel change in driving force for larger alkyllysines, which weaken cation-π interactions but increases dispersion forces, resulting in tighter binding. This GCE-SAR approach establishes discrete energetic contributions to binding from both ligand and protein, providing a powerful tool to gain mechanistic understanding of SAR trends.

Indexed as

Chromobox Protein Homolog 5Genetic CodeHumansLigandsLysineMolecular StructureMutagenesis, Site-DirectedPeptidomimeticsProtein BindingStatic ElectricityStructure-Activity RelationshipCBX5 protein, humanChromobox Protein Homolog 5LigandsLysinePeptidomimetics

Identifiers

PMID35014255
PMCPMC9048841
OpenAlexW4206558002

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.